Evidence map›Paper›PMID 33847829›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021

Identifying classes of the pain, fatigue, and depression symptom cluster in long-term prostate cancer survivors-results from the multi-regional Prostate Cancer Survivorship Study in Switzerland (PROCAS).

Salome Adam, Melissa S Y Thong, Eva Martin-Diener, Bertrand Camey, Céline Egger Hayoz, Isabelle Konzelmann, Seyed Mohsen Mousavi, Christian Herrmann, Sabine Rohrmann, Miriam Wanner and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Antidepressants for the treatment of depression in people with cancer.The Cochrane database of systematic reviews · 2023
    Review
  11. Article
  12. Health-related quality of life in long-term Caribbean prostate cancer survivors: comparisons with prostate cancer-free men.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022
    Article
  13. Mixed methods research in complementary and alternative medicine: a scoping review.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2022
    Article
  14. Influencing factors of depressive symptoms in patients with malignant tumour.The Journal of international medical research · 2021
    Article
  15. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Salome AdamNational Institute for Cancer Epidemiology and Registration (NICER), c/o University of Zurich, Zurich, Switzerland.
Melissa S Y ThongUnit of Cancer Survivorship, German Cancer Research Center (DKFZ), Heidelberg, Germany. m.thong@dkfz-heidelberg.de.ORCID https://orcid.org/0000-0002-6987-705X
Eva Martin-DienerDivision of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Bertrand CameyFribourg Cancer Registry, Fribourg, Switzerland.
Céline Egger HayozFribourg Cancer Registry, Fribourg, Switzerland.
Isabelle KonzelmannHealth Observatory Valais, Valais Cancer Registry, Sion, Switzerland.
Seyed Mohsen MousaviCancer Registry East Switzerland, St. Gallen, Switzerland.
Christian HerrmannCancer Registry East Switzerland, St. Gallen, Switzerland.
Sabine RohrmannDivision of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Miriam WannerDivision of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Katharina StaehelinBasel Cancer Registry, Cantonal Department of Health, Basel, Switzerland.
Räto T StrebelDepartment of Urology, Graubünden Cantonal Hospital, Chur, Switzerland.
Marco RandazzoDepartment of Urology, GZO Spital Wetzikon AG, Wetzikon, Switzerland.
Hubert JohnDepartment of Urology, Winterthur Cantonal Hospital, Winterthur, Switzerland.
Hans-Peter SchmidDepartment of Urology, School of Medicine (Med-HSG), St. Gallen, Switzerland.
Anita FellerNational Institute for Cancer Epidemiology and Registration (NICER), c/o University of Zurich, Zurich, Switzerland.
Volker ArndtNational Institute for Cancer Epidemiology and Registration (NICER), c/o University of Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0001-9320-8684
University of Zurich · CHUniversity of St.Gallen · CHFribourg Development Agency · CHGerman Cancer Research Center · DEKantonsspital Winterthur · CHKantonsspital Graubünden · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAside from urological and sexual problems, long-term (≥5 years after initial diagnosis) prostate cancer (PC) survivors might suffer from pain, fatigue, and depression. These concurrent symptoms can form a cluster. In this study, we aimed to investigate classes of this symptom cluster in long-term PC survivors, to classify PC survivors accordingly, and to explore associations between classes of this cluster and health-related quality of life (HRQoL).

methodsSix hundred fifty-three stage T1-T3N0M0 survivors were identified from the Prostate Cancer Survivorship in Switzerland (PROCAS) study. Fatigue was assessed with the EORTC QLQ-FA12, depressive symptoms with the MHI-5, and pain with the EORTC QLQ-C30 questionnaire. Latent class analysis was used to derive cluster classes. Factors associated with the derived classes were determined using multinomial logistic regression analysis.

resultsThree classes were identified: class 1 (61.4%) - "low pain, low physical and emotional fatigue, moderate depressive symptoms"; class 2 (15.1%) - "low physical fatigue and pain, moderate emotional fatigue, high depressive symptoms"; class 3 (23.5%) - high scores for all symptoms. Survivors in classes 2 and 3 were more likely to be physically inactive, report a history of depression or some other specific comorbidity, be treated with radiation therapy, and have worse HRQoL outcomes compared to class 1.

conclusionThree distinct classes of the pain, fatigue, and depression cluster were identified, which are associated with treatment, comorbidities, lifestyle factors, and HRQoL outcomes. Improving classification of PC survivors according to severity of multiple symptoms could assist in developing interventions tailored to survivors' needs.

Indexed as

Cancer SurvivorsProstatic NeoplasmsDepressionFatigueHumansMalePainQuality of LifeSurveys and QuestionnairesSurvivorshipSwitzerlandSyndromeClassesDepressionFatiguePainProstate cancerSymptom cluster

Identifiers

PMID33847829
PMCPMC8464556
OpenAlexW3152800891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.